ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

Agencies Announce Plans To Monitor Gene Therapy Trials.

March 10, 2000

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994

Clearinghouse Agrees: Three Dyes, Hair Color Agent Are Carcinogens; Risk To Humans – Brown

May 5, 1978

Young Reappointed BSA Chairman.

November 30, 2007

NCI Amends FCRF RFP, Extends Deadline To Nov. 10

August 22, 1986

White House Expected To Nominate Nobel Laureate Harold Varmus As NCI Director

March 17, 2010